The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson

Relationship of time to metastasis (TTM) and site of metastases in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Results from the phase 3 SPARTAN trial.
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Bayer; Gilead Sciences; Janssen Oncology; Pfizer
Research Funding - Bayer (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst)
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Janssen Oncology; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Dana E. Rathkopf
Consulting or Advisory Role - Genentech/Roche; Janssen Oncology; TRACON Pharma
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Boris A. Hadaschik
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen
Research Funding - Astellas Pharma; Bristol-Myers Squibb; German Cancer Aid; German Research Foundation; Janssen; Profound Medical
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen
 
Simon Chowdhury
Honoraria - Astellas Pharma; Clovis Oncology; Johnson & Johnson; Sanofi
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Johnson & Johnson; Sanofi
Speakers' Bureau - Astellas Pharma; Clovis Oncology; Johnson & Johnson; Sanofi
Research Funding - Astellas Pharma; Clovis Oncology; Johnson & Johnson; Sanofi
 
Margaret K. Yu
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Research Funding - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Angela Lopez-Gitlitz
No Relationships to Disclose
 
Oliver Brendan Rooney
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Mohamed Darif
No Relationships to Disclose
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Fortis; Gilead Sciences; Valeant Pharmaceuticals International
Research Funding - Janssen (Inst)